ReviewJournal of cancer research and clinical oncology2024

BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report.

Lan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.